title: From transcriptional regulation to drugging the cancer epigenome.
abstract: Jay Bradner discusses the opportunities and challenges for the study and therapeutic targeting of the cancer epigenome, as well as innovative approaches to drug discovery.
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115 USA.
authors.forename: James E
authors.initials: JE
authors.lastname: Bradner